Skip to main content

Table 7 Common KEGG pathways in gut metabolites and m6A related to cholesterol and cognition

From: Linking oxysterols and different stages of mild cognitive impairment: insights from gut metabolites and N6-methyladenosine

First Category

Second Category

Pathway Description

Pathway ID

Human Diseases

Neurodegenerative disease

Spinocerebellar ataxia

map05017

Parkinson disease

map05012

Huntington disease

map05016

Amyotrophic lateral sclerosis

map05014

Infectious disease: bacterial

Shigellosis

Tuberculosis

map05131

map05152

Infectious disease: parasitic

African trypanosomiasis

map05143

Metabolism

Lipid metabolism

Glycerophospholipid metabolism

map00564

Amino acid metabolism

Valine, leucine and isoleucine biosynthesis

Cysteine and methionine metabolism

Lysine degradation

map00290

map00270

map00310

Carbohydrate metabolism

Glyoxylate and dicarboxylate metabolism

map00630

Metabolism of other amino acids

Glutathione metabolism

map00480

Nucleotide metabolism

Purine metabolism

map00230

Organismal Systems

Nervous system

Dopaminergic synapse

map04728

Serotonergic synapse

map04726

Retrograde endocannabinoid signaling

map04723

Long-term potentiation

map04720

Digestive system

Cholesterol metabolism

map04979

Mineral absorption

map04978

Endocrine system

Melanogenesis

Parathyroid hormone synthesis, secretion and action

Prolactin signaling pathway

map04916 map04928

map04917

Environmental adaptation

Circadian entrainment

map04713

Immune system

Fc epsilon RI signaling pathway

map04664

Cellular Processes

Cell growth and death

Ferroptosis

map04216

Environmental Information Processing

Signal transduction

FoxO signaling pathway

Phospholipase D signaling pathway

map04068

map04072

Signaling molecules and interaction

Neuroactive ligand-receptor interaction

map04080